Additional Documents

1 PDF: Additional information provided by the Alcohol and Drug Foundation in relation to public hearing appearance on 2 May 2024; received 3 May 2024 Additional information provided by the Alcohol and Drug Foundation in relation to public hearing appearance on 2 May 2024; received 3 May 2024
2 PDF: Additional information provided by Associate Professor Michelle Jongenelis and Abby Robinson in relation to public hearing appearance on 2 May 2024; received 3 May 2024 Additional information provided by Associate Professor Michelle Jongenelis and Abby Robinson in relation to public hearing appearance on 2 May 2024; received 3 May 2024
3 PDF: Additional information provided by Associate Professor Michelle Jongenelis in relation to public hearing appearance on 2 May 2024; received 3 May 2024 Additional information provided by Associate Professor Michelle Jongenelis in relation to public hearing appearance on 2 May 2024; received 3 May 2024
4 PDF: Additional information provided by Liber Pharmaceutical in response to adverse comment by Vape4life made at a public hearing appearance on 2 May 2024; received 7 May 2024 Additional information provided by Liber Pharmaceutical in response to adverse comment by Vape4life made at a public hearing appearance on 2 May 2024; received 7 May 2024

See Also

Other information presented to the inquiry

Committee Secretariat contact:

Committee Secretary
Senate Standing Committees on Community Affairs
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3515
community.affairs.sen@aph.gov.au